Reward Sensitivity Digital Intervention for Suicide Risk
Pilot Development of a Youth-Focused Digital Just-in-Time Adaptive Intervention to Enhance Reward Sensitivity and Reduce Suicidal Ideation
Who can join
Ages 13 to 17 · All sexes
Full eligibility criteria
Inclusion Criteria: ADOLESCENTS * Aged 13-17 years old * Recent suicidal ideation * Access to a smartphone device * Residing in the Philadelphia metropolitan area LEGALGUARDIANS * They are the legal guardian of an adolescent that meets all study criteria (see above) * They can read, write, and speak English Exclusion Criteria: ADOLESCENTS * Psychotic disorder, including schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified, with a past year psychotic episode prior to baseline * Bipolar disorder I diagnosis, with a past year manic episode prior to baseline * Imminent suicide risk (e.g., active suicidal ideation with a specific plan and intent) LEGALGUARDIANS \- There are no exclusion criteria for legal guardians
About the study
The goal of this clinical trial is to develop and test an app designed to reduce suicide risk and improve emotional well-being in adolescents. The study will test if the app's daily check ins and recommended mood boosting skills will improve the adolescent's overall mood and suicidality. The main question it aims to answer is:
• Is the app practical and acceptable to use daily?
In the study, adolescents will:
* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete surveys and assessments on their mood, thoughts, and experiences. * Complete assessments about their app experience.
In the study, the legal guardian of the adolescent will:
* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete assessments about their app experience.
What is being tested
- Suicide prevention treatment (behavioral)
Sponsor: University of Pennsylvania · Participants: 20 · Started: Aug 21, 2026
Contact the study team
- Sydney Lempert, B.A. · Phone: 215-746-3337
Official record on ClinicalTrials.gov — NCT07661901
Locations in the U.S.
| Pennsylvania | University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.